Colgate-Palmolive CL Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Colgate-Palmolive in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Colgate-Palmolive’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Colgate-Palmolive's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Colgate-Palmolive's cash & equivalents?
- Colgate-Palmolive (CL) reported cash & equivalents of $1.34B in Q1 2026.
- How has Colgate-Palmolive's cash & equivalents changed year-over-year?
- Colgate-Palmolive's cash & equivalents increased by 20.1% year-over-year, from $1.11B to $1.34B.
- What is the long-term trend for Colgate-Palmolive's cash & equivalents?
- Over 5 years (2020 to 2025), Colgate-Palmolive's cash & equivalents has grown at a 7.7% compound annual growth rate (CAGR), from $888M to $1.29B.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.